Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$205.27 USD
+3.94 (1.96%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $205.42 +0.15 (0.07%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $2.49 | -2.92% |
Earnings Summary
For their last quarter, Charles River Laboratories International (CRL) reported earnings of $2.80 per share, beating the Zacks Consensus Estimate of $2.39 per share. This reflects a positive earnings surprise of 17.15%. Look out for CRL's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of $2.49 per share, reflecting a year-over-year decrease of 8.46%.
Earnings History
Price & Consensus
Zacks News for CRL
Charles River (CRL) Q2 Earnings Beat Estimates, 2024 View Down
CRL: What are Zacks experts saying now?
Zacks Private Portfolio Services